Latest Breaking News On - Robertj mentz - Page 4 : comparemela.com

ARNI Again Shows Modest Benefits in HF With Mid-Range EF

Randomized trial suggests benefit is largely in those with 40-60% ejection fraction

North carolinaUnited statesColl cardiolHector venturaRobertj mentzJournal of the american college cardiologyVascular instituteDuke clinical research institute in durhamDuke clinical research instituteAmerican collegeJohn ochsner heartNew orleans

The Prevalence of Heart Failure and Challenges in its Management

Javed Butler, MD, MPH, MBA, and Robert J. Mentz, MD, review the current prevalence of heart failure in the US and Europe, as well as the clinical and economic challenges that arise with increasing prevalence.

Javed butlerRobertj mentzEmerging evidenceGuide patient centric treatment selectionHeart failure

Mortality Similar With Torsemide, Furosemide for Patients Hospitalized With Heart Failure

Mortality Similar With Torsemide, Furosemide for Patients Hospitalized With Heart Failure
renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.

North carolinaUnited statesRobertj mentzDuke clinical research institute in durhamJournal of the american medical associationHealthday newsAmerican medicalDuke clinical research institute

Comparison of diuretics shows no difference in heart failure survival

Two drugs widely used to treat adults with heart failure – furosemide and torsemide – showed no difference in their ability to improve patient survival when compared, according to findings from a clinical trial supported by the National Institutes of Health. The trial, one of the largest to date studying routine medications in heart failure,Two drugs widely used to treat adults with heart failure – furosemide and torsemide – showed no difference in their ability to improve patient survival when compared, according to findings from a clinical trial supported by the National Institutes of Health. The trial, one of the largest to date studying routine medications in heart failure, » The FINANCIAL Health&Beauty

United statesNorth carolinaDuke university medical centerDavid goffPatrice desvigne nickensRobertj mentzCenters for diseaseAmerican heart associationArrhythmias branchDivision of cardiovascular sciencesNational institutes of healthDivision of cardiologyJournal of the american medical associationBlood instituteNational heartNational institutes

Study finds no difference in the survival benefit of two diuretics for heart failure patients

Two drugs widely used to treat adults with heart failure – furosemide and torsemide – showed no difference in their ability to improve patient survival when compared, according to findings from a clinical trial supported by the National Institutes of Health.

United statesNorth carolinaDuke university medical centerDavid goffPatrice desvigne nickensRobertj mentzEmily hendersonCenters for diseaseAmerican heart associationArrhythmias branchDivision of cardiovascular sciencesNational institutes of healthDivision of cardiologyJournal of the american medical associationBlood instituteNational heart